Superkrane Mitra Utama Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Superkrane Mitra Utama Tbk. trades at Rp418 (market cap 2.96T, 648.5K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,580 (market cap 11.68T, 429.7K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 3.9× Superkrane Mitra Utama Tbk.'s market cap, and Superkrane Mitra Utama Tbk. is more actively traded (648.5K versus 429.7K). Which is the better fit depends on your goals.
| SKRN | TSPC | |
|---|---|---|
Market Cap | 2.96T | 11.68T |
Volume | 648.5K | 429.7K |
Lot | 6.49K | 4.3K |
Turnover | 266.83M | 1.11B |
Average Price | 411.45 | 2,591.65 |
Value | 266.83M | 1.11B |
Indicative Equilibrium Price | 418 | 2,580 |
Indicative Equilibrium Volume | 102 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Superkrane Mitra Utama Tbk (the Company) was established based on Deed No. 285 by notary Ratna Komala Komar, S.H., dated March 27, 1996, in Jakarta.
Read more on SKRN →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →